323 related articles for article (PubMed ID: 9245212)
1. [Opioid intoxication. Inappropriate administration of transdermal fentanyl].
Klockgether-Radke A; Hildebrandt J
Anaesthesist; 1997 May; 46(5):428-9. PubMed ID: 9245212
[TBL] [Abstract][Full Text] [Related]
2. Heat-related toxicity with the fentanyl transdermal patch.
Newshan G
J Pain Symptom Manage; 1998 Nov; 16(5):277-8. PubMed ID: 9846020
[No Abstract] [Full Text] [Related]
3. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
Muijsers RB; Wagstaff AJ
Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
[TBL] [Abstract][Full Text] [Related]
4. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
5. A pitfall to avoid when starting a patient on transdermal fentanyl.
Low JA; Chye R
Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
[TBL] [Abstract][Full Text] [Related]
6. A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications.
Bain KT
J Opioid Manag; 2006; 2(6):314-24. PubMed ID: 17326593
[TBL] [Abstract][Full Text] [Related]
7. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
8. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
10. [Direct low-dose fentanyl patch (2.1mg) introduction for opioid naïve outpatients with cancer pain].
Hata A; Katakami N; Masuda Y; Nanjo S; Otsuka K; Kaji R; Fujita S; Iwamori S; Mifune Y; Orita H; Fukae M; Yamatani T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):415-8. PubMed ID: 21403444
[TBL] [Abstract][Full Text] [Related]
11. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain.
Donner B; Zenz M; Tryba M; Strumpf M
Pain; 1996 Mar; 64(3):527-534. PubMed ID: 8783318
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl nasal spray (Lazanda) for pain.
Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
Garbe E; Jobski K; Schmid U
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):191-8. PubMed ID: 21681850
[TBL] [Abstract][Full Text] [Related]
15. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
[TBL] [Abstract][Full Text] [Related]
16. A study of the use of a transdermal fentanyl patch in cats.
Scherk-Nixon M
J Am Anim Hosp Assoc; 1996; 32(1):19-24. PubMed ID: 8963731
[TBL] [Abstract][Full Text] [Related]
17. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.
Hair PI; Keating GM; McKeage K
Drugs; 2008; 68(14):2001-9. PubMed ID: 18778121
[TBL] [Abstract][Full Text] [Related]
18. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
[TBL] [Abstract][Full Text] [Related]
19. Pain recurrence on the third day after application of a transdermal fentanyl patch.
Konishi H; Ishihara C; Chiba M; Endo Y; Yamaji A
Pharm World Sci; 2005 Aug; 27(4):353. PubMed ID: 16228637
[No Abstract] [Full Text] [Related]
20. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]